Metsera

New York, NY

Metsera operates as a clinical-stage biopharmaceutical company.

Company Details

Founded: 2022
Employees: Between 50 - 100 employees
Raised: $505,000,000
Headquarters Location: New York, NY
Public: Yes
Acquired: Yes
CEO: Christopher Whitten Bernard
Founders: Whit Bernard

Company Collections

These are collections Metsera is a part of. Click on the collection name to view similar companies.

Metsera's Investors

Metsera's Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

Metsera Headquarters Location

3 World Trade Center, New York, NY 10007

Total Amount Raised: $505,000,000

Metsera's Investors

Metsera Funding Rounds

IPO
Unknown
Jan 1, 2025
Series B
$215,000,000
Nov 12, 2024
Series B Investors
Venrock Healthcare Capital Partners
Wellington Management
Janus Henderson Investors
Fidelity Investments
Arch Venture Partners
RA Capital Management
GV
Newpath Management
Viking Global Investors
Deep Track Capital
SymBiosis
SVF
Alpha Wave Global
T. Rowe Price
Series A
$290,000,000
Apr 17, 2024
Series A Investors
Arch Venture Partners
SVF
Newpath Management
Mubadala Capital Ventures
GV
F-Prime Capital

Funding info provided by Diffbot.

Metsera Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Metsera.